%PDF-1.5
%
1 0 obj
<<
/Lang (en)
/MarkInfo <<
/Marked true
>>
/Metadata 2 0 R
/Outlines 3 0 R
/PageLayout /OneColumn
/PageMode /UseOutlines
/Pages 4 0 R
/StructTreeRoot 5 0 R
/Type /Catalog
/ViewerPreferences <<
/DisplayDocTitle true
>>
>>
endobj
6 0 obj
<<
/Author (Gemeinsamer Bundesausschuss/Federal Joint Committee \(g-ba.de\))
/Category ()
/Comments ()
/Company ()
/CreationDate (D:20211014141428+02'00')
/Creator <4163726F626174205044464D616B65722031352066FC7220576F7264>
/Keywords <416E6E657820584949202D2042656E65666974204173736573736D656E74206F66204D65646963696E616C2050726F64756374732077697468204E65772041637469766520496E6772656469656E7473206163636F7264696E6720746F2053656374696F6E203335612053474220563A0D0A466F7374656D736176697220286D756C74696472756720726573697374616E74204849562D3120696E66656374696F6E29>
/ModDate (D:20211014143907+02'00')
/Producer (Adobe PDF Library 15.0)
/SourceModified (D:20211013090654)
/Subject (Pharmaceuticals Directive: )
/Title (Resolution)
/_DocHome (1460877555)
>>
endobj
2 0 obj
<<
/Length 4921
/Subtype /XML
/Type /Metadata
>>
stream
2021-10-14T14:39:07+02:00
2021-10-14T14:14:28+02:00
2021-10-14T14:39:07+02:00
Acrobat PDFMaker 15 für Word
uuid:9b2d240e-65cb-40a9-9931-af7f69009d8c
uuid:cbb841ec-fa66-4b6c-b263-a5e15169145b
1
application/pdf
Resolution
Pharmaceuticals Directive:
Gemeinsamer Bundesausschuss/Federal Joint Committee (g-ba.de)
Annex XII - Benefit Assessment of Medicinal Products with New Active Ingredients according to Section 35a SGB V:
Fostemsavir (multidrug resistant HIV-1 infection)
Adobe PDF Library 15.0
Annex XII - Benefit Assessment of Medicinal Products with New Active Ingredients according to Section 35a SGB V:
Fostemsavir (multidrug resistant HIV-1 infection)
D:20211013090654
1460877555
Arzneimittel-Richtlinie: Anlage XII â•fi Nutzenbewertung von Arzneimitteln mit neuen Wirkstoffen nach § 35a SGB V
endstream
endobj
3 0 obj
<<
/Count 8
/First 7 0 R
/Last 8 0 R
/Type /Outlines
>>
endobj
4 0 obj
<<
/Count 5
/Kids [9 0 R 10 0 R 11 0 R 12 0 R 13 0 R]
/Type /Pages
>>
endobj
5 0 obj
<<
/K 14 0 R
/ParentTree 15 0 R
/ParentTreeNextKey 11
/RoleMap 16 0 R
/Type /StructTreeRoot
>>
endobj
7 0 obj
<<
/A 17 0 R
/Next 18 0 R
/Parent 3 0 R
/Title (Resolution)
>>
endobj
8 0 obj
<<
/A 19 0 R
/Parent 3 0 R
/Prev 20 0 R
/Title (II. The resolution will enter into force on the day of its publication on the website of the G-BA on 16 September 2021.)
>>
endobj
9 0 obj
<<
/Contents [21 0 R 22 0 R 23 0 R 24 0 R 25 0 R 26 0 R 27 0 R 28 0 R 29 0 R]
/CropBox [0.0 0.0 595.32 841.92]
/MediaBox [0.0 0.0 595.32 841.92]
/Parent 4 0 R
/Resources <<
/ColorSpace <<
/CS0 [/ICCBased 30 0 R]
/CS1 [/ICCBased 31 0 R]
>>
/Font <<
/TT0 32 0 R
/TT1 33 0 R
/TT2 34 0 R
>>
/XObject <<
/OL1 35 0 R
>>
>>
/Rotate 0
/StructParents 0
/Tabs /S
/Type /Page
>>
endobj
10 0 obj
<<
/Contents [36 0 R 37 0 R]
/CropBox [0.0 0.0 595.32 841.92]
/MediaBox [0.0 0.0 595.32 841.92]
/Parent 4 0 R
/Resources <<
/ColorSpace <<
/CS0 [/ICCBased 30 0 R]
>>
/Font <<
/TT0 32 0 R
/TT1 33 0 R
/TT2 34 0 R
/TT3 38 0 R
>>
/XObject <<
/OL1 35 0 R
>>
>>
/Rotate 0
/StructParents 1
/Tabs /S
/Type /Page
>>
endobj
11 0 obj
<<
/Annots [39 0 R 40 0 R]
/Contents [41 0 R 42 0 R]
/CropBox [0.0 0.0 595.32 841.92]
/MediaBox [0.0 0.0 595.32 841.92]
/Parent 4 0 R
/Resources <<
/ColorSpace <<
/CS0 [/ICCBased 30 0 R]
/CS1 [/ICCBased 31 0 R]
>>
/Font <<
/C2_0 43 0 R
/C2_1 44 0 R
/TT0 32 0 R
/TT1 33 0 R
/TT2 34 0 R
>>
/XObject <<
/OL1 35 0 R
>>
>>
/Rotate 0
/StructParents 2
/Tabs /S
/Type /Page
>>
endobj
12 0 obj
<<
/Annots [45 0 R 46 0 R]
/Contents [47 0 R 48 0 R]
/CropBox [0.0 0.0 595.32 841.92]
/MediaBox [0.0 0.0 595.32 841.92]
/Parent 4 0 R
/Resources <<
/ColorSpace <<
/CS0 [/ICCBased 30 0 R]
>>
/Font <<
/TT0 32 0 R
/TT1 33 0 R
/TT2 34 0 R
>>
/XObject <<
/OL1 35 0 R
>>
>>
/Rotate 0
/StructParents 5
/Tabs /S
/Type /Page
>>
endobj
13 0 obj
<<
/Annots [49 0 R 50 0 R]
/Contents [51 0 R 52 0 R]
/CropBox [0.0 0.0 595.32 841.92]
/MediaBox [0.0 0.0 595.32 841.92]
/Parent 4 0 R
/Resources <<
/ColorSpace <<
/CS0 [/ICCBased 30 0 R]
/CS1 [/ICCBased 31 0 R]
>>
/Font <<
/TT0 32 0 R
/TT1 33 0 R
/TT2 34 0 R
>>
/XObject <<
/OL1 35 0 R
>>
>>
/Rotate 0
/StructParents 7
/Tabs /S
/Type /Page
>>
endobj
14 0 obj
<<
/K [53 0 R 54 0 R 55 0 R 56 0 R 57 0 R 58 0 R 59 0 R 60 0 R 61 0 R 62 0 R
63 0 R 64 0 R 65 0 R 66 0 R 67 0 R 68 0 R 69 0 R 70 0 R 71 0 R 72 0 R
73 0 R 74 0 R 75 0 R 76 0 R 77 0 R 78 0 R 79 0 R 80 0 R 81 0 R 82 0 R
83 0 R 84 0 R 85 0 R 86 0 R 87 0 R 88 0 R 89 0 R 90 0 R 91 0 R 92 0 R
93 0 R 94 0 R 95 0 R 96 0 R 97 0 R 98 0 R 99 0 R 100 0 R 101 0 R 102 0 R
103 0 R 104 0 R 105 0 R 106 0 R 107 0 R 108 0 R 109 0 R 110 0 R 111 0 R 112 0 R]
/P 5 0 R
/S /Sect
>>
endobj
15 0 obj
<<
/Nums [0 [53 0 R 54 0 R 55 0 R 56 0 R 57 0 R 58 0 R 59 0 R 60 0 R]
1 [61 0 R 62 0 R 63 0 R 64 0 R 65 0 R 66 0 R 67 0 R 68 0 R 69 0 R 70 0 R
71 0 R null 73 0 R 74 0 R 75 0 R 76 0 R 77 0 R 78 0 R null 80 0 R
81 0 R 82 0 R 113 0 R 72 0 R 114 0 R]
2 [83 0 R null 115 0 R null 116 0 R null null 117 0 R null 118 0 R
null 119 0 R null null 120 0 R null 121 0 R null 122 0 R null
123 0 R null 124 0 R 125 0 R 126 0 R null 127 0 R null 128 0 R 129 0 R
130 0 R null 131 0 R null 132 0 R 133 0 R 134 0 R null 135 0 R null
136 0 R 137 0 R 138 0 R null 139 0 R null 140 0 R null 141 0 R null
142 0 R null 143 0 R null 144 0 R null 145 0 R null 146 0 R null
147 0 R 85 0 R 86 0 R null 88 0 R 89 0 R 90 0 R 91 0 R 92 0 R null
null null 94 0 R 95 0 R 96 0 R 148 0 R 87 0 R 149 0 R 150 0 R]
3 151 0 R 4 151 0 R
5 [97 0 R 98 0 R 99 0 R null 152 0 R null 153 0 R null null 154 0 R
null 155 0 R null 156 0 R null 157 0 R null 158 0 R null 159 0 R
null 160 0 R null 161 0 R 162 0 R null 163 0 R null 164 0 R 165 0 R
null 166 0 R null 167 0 R null 168 0 R null 169 0 R 170 0 R null
null 171 0 R 172 0 R 102 0 R 103 0 R 104 0 R 105 0 R null 173 0 R null
174 0 R null 175 0 R null null 176 0 R null 177 0 R null null
178 0 R null 179 0 R null 180 0 R null null 181 0 R null 182 0 R
null 183 0 R null null 184 0 R null 185 0 R null 186 0 R null
187 0 R null null 188 0 R null 189 0 R null 190 0 R null 191 0 R
null 192 0 R null 193 0 R null 194 0 R 195 0 R 196 0 R 197 0 R 198 0 R
199 0 R null null null null null null 200 0 R null 201 0 R
163 0 R 202 0 R]
6 170 0 R 7 [107 0 R 108 0 R null null 109 0 R 110 0 R 111 0 R 112 0 R 203 0 R 204 0 R]
8 205 0 R 9 205 0 R
10 201 0 R]
>>
endobj
16 0 obj
<<
/Annotation /Span
/Artifact /P
/Bibliography /BibEntry
/Chart /Figure
/Diagram /Figure
/DropCap /Figure
/Endnote /Note
/Footnote /Note
/Fu#C3#9Fnotenzeichen /Span
/GBA_Aufz#C3#A4hlung#201. /P
/GBA_Datum /P
/GBA_Standard /P
/GBA_Verfasser /P
/Hyperlink /Span
/InlineShape /Figure
/Outline /Span
/Standard /P
/Strikeout /Span
/Subscript /Span
/Superscript /Span
/TextBox /Art
/Underline /Span
/Untertitel /H2
/#C3#9Cberschrift#201 /H1
/#C3#9Cberschrift#204 /H4
>>
endobj
17 0 obj
<<
/D [9 0 R /XYZ 69 743 0.0]
/S /GoTo
>>
endobj
18 0 obj
<<
/A 206 0 R
/Next 20 0 R
/Parent 3 0 R
/Prev 7 0 R
/Title (of the Federal Joint Committee on an Amendment of the Pharmaceuticals Directive: Annex XII - Benefit Assessment of Medicinal Products with New Active Ingredients according to Section 35a SGB V:)
>>
endobj
19 0 obj
<<
/D [13 0 R /XYZ 69 743 0.0]
/S /GoTo
>>
endobj
20 0 obj
<<
/A 207 0 R
/Count 4
/First 208 0 R
/Last 209 0 R
/Next 8 0 R
/Parent 3 0 R
/Prev 18 0 R
/Title (I. Annex XII shall be amended in alphabetical order to include the active ingredient fostemsavir as follows:)
>>
endobj
21 0 obj
<<
/Length 37
/Filter /FlateDecode
>>
stream
x+*23P0bdBr.KB W
endstream
endobj
22 0 obj
<<
/Length 780
/Filter /FlateDecode
>>
stream
HUn1Wv-E $ CЃq yڿZ;]8iE,#R=/ofG|^\ᑾ̎~EC)Ļ!8Wߝ}rLs{4vs?_<:MxzqgəeR4pIs!
>3.8`N"2Hj|'Â#gWtH"v}r V e̻ C\HAiU!M Rze$b?ܐvwmGXJ/UZky&WiܚbbQY,G$E?(uTQBҩ2LY#G
MʆW $=N ۮ`Â]р~9'g̲3;%')j
jjIY<C˧)MhՠiوίBZS۪*XSJhW@
m5@6(Рн)/jGDZj"7[|5fA>( v\twLvpY>,;x
./]_"ӗ+?6bO>]v7|7ke'?=NZWdtgә3uj;BC}tzjE^lf_ H
endstream
endobj
23 0 obj
<<
/Length 812
/Filter /FlateDecode
>>
stream
HUInA+m*3/@<%'"h#[ٵrzGc=n߶/{CsƓ}}G4}5}{>oOzgi-uu+mowY[-DR+&$5 {w6Vޓ5:(A9;N jeA2#t;'^`
p#qZS]W,RXL ʣag aʕzXMcV9b-Š[7ZL7DpAD]Lr$Y'^.,}$\hU^*b6fQ_+]Mp0
e(w/CH!3Tt!NXeFoj&k1ma=1'T7|3ڙuٙ$ix'`ɔꪩBxaI`ǹ4rU( 5^zͨ5J+IZ/mUVa Xp]~H;6ExE@MYܙ<f6D"+bJQO8+Z)RzPtb?YXahy;u t(otzINK`UZ^;[w 1UqdSWme0{:h7aƚ53X
0B]@1*V:=#ܭhF7Il\VD}hu]csVC !@
N Œ孙RgHN>PmMH5
e4O
endstream
endobj
24 0 obj
<<
/Length 790
/Filter /FlateDecode
>>
stream
HU[j1Srhs#`SUu6geQKխRx:R%\ k4y%el+I`hWX1<e\n2zAjܥjJ
#3N<x8|b>5Aʫap>_~//9dy0y"K461q3.C7=l``V,|hѭd6Zd$_L-Q|KK+[h^[Y.ךI,B+(92#(G9J29'oh'oJM/R62M2؇"p]X}I3`_
xQP,L>ΣdⅩd-DBP^ޯPB6
m.JdYH"NK;U;<;LR9bnK"v~e0=@o3z>i=gEnP IGQI;s85-?3 ֝hiBm$THD^3R]cagkMWg.f 'c65i%)S5J'Čho65 0t~1ε`so J0>flE6zi,P)i|C.%Piîb=x1;RLH^Iҡ*7a2W5l-}.C.|KcndSvaEI|BZߩL37W(`
endstream
endobj
25 0 obj
<<
/Length 592
/Filter /FlateDecode
>>
stream
HKnADs
^`& A@*ORXG,A4XLƔ]QUA3!!{
|mx=0ς۷>/[zJunY>{4[HFrz>}_^O?Q_2'FI;!?7&4-QԊTJiyVUH73\>rs7$|4z\f{]@,./ #
endstream
endobj
26 0 obj
<<
/Length 608
/Filter /FlateDecode
>>
stream
HM0]gD9R$h/MPcʝTfIJce~m?oc~X<rZU?۷?[|wVF[Q0oZs~(fƕ
iC0yg-zﶆ_-N`fH.I;ԴI}&)W[K5^CZZOmWДWfcv570~.>~J,.Yz4KahjWY{x,|+'*>v
RfNkW1Gu3ZϥIӡip+Mz(*Vc!UM#}VΚ¬pkwTh0
iWIP>/`,~nRֆK/i^ͭbίBkj/Z;KYSaIByKF R0(@Ę)`z֫/z5e=fmc 1Z=SMY.gl^"D#XL=۹=/4sݺx!9SZk'tȚ?(2*0@$`%
ôxõi[$fҷiňl+ @
endstream
endobj
27 0 obj
<<
/Length 761
/Filter /FlateDecode
>>
stream
HKO0w.Ta
j{0le۱c>9f%g[JI֑ftfЦ4NPzuxR|BhMc}:ܽRMR5CC iP.S
E}dxA=LD:;
9E6#g@M)
/>cP -"DPQ}rzApc
gp#E`
+4ޑd\dgTwȥ K>qT.JlX牰n9D7yA"S;yc,m"9a㝋k`2s|ab1qbGO5DTv"RE j(uI@ )x%OdcOްq.qVbAAiQ$9)VB,.$g[48BK@00i!QX#E4Xnn2v:`;jЅaW
Q/z`aWc&i5kp?KC3fyARmKJwuޫS9N^LJadoowt-^MXum1ڐmf?xq%A(U6lmXK[b}Dju?.uL.N?af9hb&H9"eܵyv+ #v
endstream
endobj
28 0 obj
<<
/Length 892
/Filter /FlateDecode
>>
stream
HUNA}WqG.sKB
IAB%B$M*H?dzلΌ9>oe.J鬀.$o
JHӝ,s4i00w4?[0qet3S$F?::d|Շ''GW -
PgZV,)$s2(K(i_G)BNU^UWԇK2=/ކcʬm
(7XXu",
*&KA6,MeRL (FkjKz"ԓG\ea"kV`'.aJ}s>#gǨEE
vfWKR0LrH:\XЎ09ST`wfk#"tB u.8LWRR06tz8t\*eQ<aJ`X{jge׀hRz*.3Ⱥo*nKcށh)*1Q tDk"%T6LB9
>vqُ+s>dŹxYk
u<va~Sܟq]'֎F.DSVlNB_-JQRzs1jC94Ů9"=G;CK[2,ȋN>t u
6 z7ߐ